We Study Billionaires - The Investor’s Podcast Network cover image

TIP528: Mastermind Q1 2023 w/ Tobias Carlisle and Hari Ramachandra

We Study Billionaires - The Investor’s Podcast Network

CHAPTER

Navigating Biotech Investments

This chapter discusses the complexities of investing in biotechnology firms, emphasizing the impact of patent expirations and competition on profitability. The analysis includes financial metrics of companies like Amgen, advocating for a diversified investment approach in the biotech sector. Additionally, it highlights the significance of indicators like the 10-3 yield inversion in guiding investment strategies amid volatile market conditions.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner